James F Emigh - Net Worth and Insider Trading
James F Emigh Net Worth
The estimated net worth of James F Emigh is at least $12,091 dollars as of 2024-06-24. James F Emigh is the VP Corporate Development of Acura Pharmaceuticals Inc and owns about 439,660 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $12,091. Details can be seen in James F Emigh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James F Emigh has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).
Transaction Summary of James F Emigh
James F Emigh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F Emigh owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .
Click here to see the complete history of James F Emigh’s form 4 insider trades.
Insider Ownership Summary of James F Emigh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | VP & Corporate Development |
James F Emigh Latest Holdings Summary
James F Emigh currently owns a total of 1 stock. James F Emigh owns 439,660 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $12,091.
Latest Holdings of James F Emigh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 439,660 | 0.03 | 12,091 |
Holding Weightings of James F Emigh
James F Emigh Form 4 Trading Tracker
According to the SEC Form 4 filings, James F Emigh has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 400,000 shares on December 14, 2017, which cost James F Emigh around $40,000.
Insider Trading History of James F Emigh
- 1
James F Emigh Trading Performance
GuruFocus tracks the stock performance after each of James F Emigh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James F Emigh is 67.65%. GuruFocus also compares James F Emigh's trading performance to market benchmark return within the same time period. The performance of stocks bought by James F Emigh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James F Emigh's insider trading performs compared to the benchmark.
Performance of James F Emigh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 58.82 | | | | | |
| Relative Return to S&P 500(%) | 53.76 | | | | | |
James F Emigh Ownership Network
James F Emigh Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
James F Emigh is the VP & Corporate Development of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Treasurer & Controller Robert A Seiser , President & CEO Robert B Jones , and VP Pharmaceutical Sciences APT Albert W Brzeczko .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
James F Emigh Mailing Address
Above is the net worth, insider trading, and ownership report for James F Emigh. Currently GuruFocus does not have mailing address information for James F Emigh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
